Key result
Maternal late-pregnancy cyclobenzaprine use is linked to early ductal closure and neonatal persistent pulmonary hypertension.
Why the study?
Cyclobenzaprine use during late pregnancy may cause early ductal closure leading to persistent pulmonary hypertension in neonates, a potential clinical concern not previously reported.
Does maternal use of cyclobenzaprine induce early ductal closure and persistent pulmonary hypertension in neonates?
Case Report (n=1)
Does maternal use of cyclobenzaprine induce early ductal closure and persistent pulmonary hypertension in neonates?
This is the first report suggesting that maternal use of cyclobenzaprine during late pregnancy may cause early ductal closure and persistent pulmonary hypertension in neonates.
Answers are grounded in this paper and cite their sources.
May warrant caution with cyclobenzaprine in late pregnancy; hypothesis-generating and requires confirmation before practice change.
A full-term male infant presented shortly after birth with respiratory distress. An echocardiogram done within the first hour of life showed an elevated pulmonary artery pressure, an associated right ventricular hypertrophy without a patent ductus arteriosus. The patient was treated for persistent pulmonary hypertension with favorable response. Maternal history was unremarkable except for chronic low back pain treated with cyclobenzaprine (Flexeril®). A proposed mechanism for cyclobenzaprine includes inhibition of norepinephrine and serotonin reuptake, factors known to inhibit prostaglandin and nitric oxide. These two factors are the leading causes of in-utero ductal closure. This report is the first to indicate that cyclobenzaprine use during late pregnancy should be considered a potential cause of early ductal closure.
No takes yet. Share an insight, caveat, or question.
Moreira et al. (2013) conducted a case report in Persistent pulmonary hypertension and early ductal closure (n=1). Maternal use of cyclobenzaprine (Flexeril) was evaluated on Early ductal closure and persistent pulmonary hypertension. Maternal use of cyclobenzaprine during late pregnancy may induce early ductal closure and persistent pulmonary hypertension in neonates.
Synapse has enriched 10 related papers. Consider them for comparative context: